Ciprofloxacin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Alerts
• Clinical Trials
• Forums

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Condition:   Pancreatic Cancer Interventions:   Procedure: Biopsy;   Drug: FOLFIRINOX;   Drug: Ciprofloxacin;   Drug: Metronidazole;   Drug: Pembrolizumab;   Procedure: Surgical Resection Sponsor:   Icahn School of Medicine at Mount Sinai Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2022 Category: Research Source Type: clinical trials